vs

Side-by-side financial comparison of Consolidated Edison (ED) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $4.0B, roughly 1.4× Consolidated Edison). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs 7.5%, a 4.1% gap on every dollar of revenue. On growth, TENET HEALTHCARE CORP posted the faster year-over-year revenue change (9.0% vs 8.2%). Over the past eight quarters, TENET HEALTHCARE CORP's revenue compounded faster (1.5% CAGR vs -3.7%).

Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

ED vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.4× larger
THC
$5.5B
$4.0B
ED
Growing faster (revenue YoY)
THC
THC
+0.8% gap
THC
9.0%
8.2%
ED
Higher net margin
THC
THC
4.1% more per $
THC
11.7%
7.5%
ED
Faster 2-yr revenue CAGR
THC
THC
Annualised
THC
1.5%
-3.7%
ED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ED
ED
THC
THC
Revenue
$4.0B
$5.5B
Net Profit
$298.0M
$644.0M
Gross Margin
Operating Margin
12.3%
15.4%
Net Margin
7.5%
11.7%
Revenue YoY
8.2%
9.0%
Net Profit YoY
-3.9%
12.6%
EPS (diluted)
$0.81
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ED
ED
THC
THC
Q4 25
$4.0B
$5.5B
Q3 25
$4.6B
$5.3B
Q2 25
$3.6B
$5.3B
Q1 25
$4.9B
$5.2B
Q4 24
$3.7B
$5.1B
Q3 24
$4.2B
$5.1B
Q2 24
$3.3B
$5.1B
Q1 24
$4.3B
$5.4B
Net Profit
ED
ED
THC
THC
Q4 25
$298.0M
$644.0M
Q3 25
$688.0M
$579.0M
Q2 25
$246.0M
$522.0M
Q1 25
$791.0M
$622.0M
Q4 24
$310.0M
$572.0M
Q3 24
$588.0M
$681.0M
Q2 24
$202.0M
$477.0M
Q1 24
$720.0M
$2.3B
Operating Margin
ED
ED
THC
THC
Q4 25
12.3%
15.4%
Q3 25
21.2%
16.8%
Q2 25
9.8%
15.6%
Q1 25
23.0%
18.1%
Q4 24
13.0%
16.2%
Q3 24
20.4%
21.3%
Q2 24
9.7%
14.9%
Q1 24
23.6%
61.2%
Net Margin
ED
ED
THC
THC
Q4 25
7.5%
11.7%
Q3 25
15.1%
10.9%
Q2 25
6.8%
9.9%
Q1 25
16.2%
11.9%
Q4 24
8.5%
11.3%
Q3 24
13.9%
13.3%
Q2 24
6.1%
9.3%
Q1 24
16.8%
43.5%
EPS (diluted)
ED
ED
THC
THC
Q4 25
$0.81
$4.22
Q3 25
$1.90
$3.86
Q2 25
$0.68
$3.14
Q1 25
$2.25
$4.27
Q4 24
$0.89
$3.79
Q3 24
$1.69
$4.89
Q2 24
$0.58
$2.64
Q1 24
$2.08
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ED
ED
THC
THC
Cash + ST InvestmentsLiquidity on hand
$1.6B
$2.9B
Total DebtLower is stronger
$25.8B
$13.1B
Stockholders' EquityBook value
$24.2B
$4.2B
Total Assets
$74.6B
$29.7B
Debt / EquityLower = less leverage
1.07×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ED
ED
THC
THC
Q4 25
$1.6B
$2.9B
Q3 25
$181.0M
$3.0B
Q2 25
$1.5B
$2.6B
Q1 25
$360.0M
$3.0B
Q4 24
$1.3B
$3.0B
Q3 24
$93.0M
$4.1B
Q2 24
$1.5B
$2.9B
Q1 24
$169.0M
$2.5B
Total Debt
ED
ED
THC
THC
Q4 25
$25.8B
$13.1B
Q3 25
$13.1B
Q2 25
$13.1B
Q1 25
$13.1B
Q4 24
$24.7B
$13.1B
Q3 24
$12.8B
Q2 24
$12.8B
Q1 24
$12.8B
Stockholders' Equity
ED
ED
THC
THC
Q4 25
$24.2B
$4.2B
Q3 25
$24.2B
$4.0B
Q2 25
$23.8B
$3.7B
Q1 25
$23.8B
$4.2B
Q4 24
$22.0B
$4.2B
Q3 24
$21.9B
$3.8B
Q2 24
$21.6B
$3.5B
Q1 24
$21.6B
$3.5B
Total Assets
ED
ED
THC
THC
Q4 25
$74.6B
$29.7B
Q3 25
$71.8B
$29.4B
Q2 25
$71.5B
$28.7B
Q1 25
$70.7B
$29.2B
Q4 24
$70.6B
$28.9B
Q3 24
$68.6B
$29.4B
Q2 24
$67.9B
$29.3B
Q1 24
$66.7B
$28.9B
Debt / Equity
ED
ED
THC
THC
Q4 25
1.07×
3.10×
Q3 25
3.26×
Q2 25
3.49×
Q1 25
3.13×
Q4 24
1.13×
3.14×
Q3 24
3.33×
Q2 24
3.67×
Q1 24
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ED
ED
THC
THC
Operating Cash FlowLast quarter
$1.5B
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
4.97×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ED
ED
THC
THC
Q4 25
$1.5B
$731.0M
Q3 25
$504.0M
$1.1B
Q2 25
$2.0B
$936.0M
Q1 25
$837.0M
$815.0M
Q4 24
$1.3B
$-331.0M
Q3 24
$392.0M
$1.0B
Q2 24
$1.3B
$747.0M
Q1 24
$573.0M
$586.0M
Free Cash Flow
ED
ED
THC
THC
Q4 25
$367.0M
Q3 25
$778.0M
Q2 25
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
Q1 24
$346.0M
FCF Margin
ED
ED
THC
THC
Q4 25
6.6%
Q3 25
14.7%
Q2 25
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Q1 24
6.4%
Capex Intensity
ED
ED
THC
THC
Q4 25
6.6%
Q3 25
5.3%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
4.5%
Cash Conversion
ED
ED
THC
THC
Q4 25
4.97×
1.14×
Q3 25
0.73×
1.83×
Q2 25
8.04×
1.79×
Q1 25
1.06×
1.31×
Q4 24
4.23×
-0.58×
Q3 24
0.67×
1.53×
Q2 24
6.63×
1.57×
Q1 24
0.80×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ED
ED

Electricity$2.9B73%
Oil And Gas Purchased$923.0M23%
Steam Plant$189.0M5%
Con Edison Transmission$1.0M0%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons